- Home
- MOH vs RGC Comparison
MOH vs RGC Comparison
Compare MOH & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOH | RGC |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 11.5B |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MOH | RGC |
|---|---|---|
| Price | $203.68 | $8.71 |
| Analyst Decision | Hold | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $167.00 | N/A |
| AVG Volume (30 Days) | ★ 877.3K | 138.9K |
| Earning Date | 04-22-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $45,426,000,000.00 | N/A |
| Revenue This Year | $2.40 | N/A |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $728.00 | ★ N/A |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $121.06 | $9.39 |
| 52 Week High | $311.53 | $69.00 |
Technical Indicators
Market Signals| Indicator | MOH | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 63.27 | 17.41 |
| Support Level | $174.79 | N/A |
| Resistance Level | N/A | $16.97 |
| Average True Range (ATR) | 7.30 | 2.45 |
| MACD | 0.02 | -1.01 |
| Stochastic Oscillator | 96.88 | 2.34 |
Price Performance
Historical ComparisonAbout MOH Molina Healthcare Inc
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.